Seqalis
> VISIT THEIR WEBSITE
| Member type: Company |
| Core Business: Contract research organization |
| Size: [1-10] |
ABOUT SEQALIS
Seqalis marks a milestone in BIO.be’s history. Registered as a trademark in 2022, the name embodies three pillars: service, quality assurance, and life sciences.
This evolution strengthens BIO.be’s expertise in pathology, cytogenomics, and molecular biology, aiming to be a trusted partner for pharma, biotech, and academia.
In partnership with the Institute of Pathology and Genetics, Seqalis provides advanced testing, scientific advisory, and R&D services. It complies with strict quality standards, with BIO.be ISO 9001 certified and IPG ISO 15189 accredited.
Innovative platforms such as qTCR-seq, cytogenomics (Bionano OGM) for ATMP quality control, and involvement in projects like AURORA 2 confirm its leadership in personalized medicine and oncology.
Rooted in pathology, genetics, and molecular biology, Seqalis drives diagnostics, R&D, and innovation for the benefit of patients and society.
NEWS OF SEQALIS
Discover all news related to this member